WAVE Life Sciences Ltd
NASDAQ:WVE
WAVE Life Sciences Ltd
Revenue
WAVE Life Sciences Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Revenue
$113.3m
|
CAGR 3-Years
78%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
Haw Par Corporation Ltd
SGX:H02
|
Revenue
S$232.1m
|
CAGR 3-Years
28%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Revenue
S$170.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
I
|
IX Biopharma Ltd
SGX:42C
|
Revenue
S$6.1m
|
CAGR 3-Years
59%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
See Also
What is WAVE Life Sciences Ltd's Revenue?
Revenue
113.3m
USD
Based on the financial report for Dec 31, 2023, WAVE Life Sciences Ltd's Revenue amounts to 113.3m USD.
What is WAVE Life Sciences Ltd's Revenue growth rate?
Revenue CAGR 5Y
51%
Over the last year, the Revenue growth was 3 004%. The average annual Revenue growth rates for WAVE Life Sciences Ltd have been 78% over the past three years , 51% over the past five years .